EUR 1.53
(0.66%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 3.2 Million EUR | 27.96% |
2022 | 2.5 Million EUR | 105.48% |
2021 | 1.21 Million EUR | 521.75% |
2020 | 196.19 Thousand EUR | -31.59% |
2019 | 286.8 Thousand EUR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q1 | 3.09 Million EUR | 23.58% |
2023 Q4 | 3.2 Million EUR | -5.69% |
2023 FY | 2.48 Million EUR | -1.04% |
2023 Q2 | 1.91 Million EUR | -38.27% |
2023 Q3 | 3.4 Million EUR | 77.85% |
2022 Q1 | 1.5 Million EUR | 23.37% |
2022 FY | 2.5 Million EUR | 105.48% |
2022 Q4 | 2.5 Million EUR | 86.96% |
2022 Q3 | 1.34 Million EUR | -10.91% |
2022 Q2 | 1.5 Million EUR | 0.0% |
2021 Q3 | 143.46 Thousand EUR | -87.6% |
2021 Q1 | 170.71 Thousand EUR | 0.0% |
2021 FY | 1.21 Million EUR | 521.75% |
2021 Q4 | 1.21 Million EUR | 750.31% |
2021 Q2 | 1.15 Million EUR | 577.5% |
2020 FY | 196.19 Thousand EUR | -31.59% |
2019 FY | 286.8 Thousand EUR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Affluent Medical SA | 14.41 Million EUR | 77.743% |
Bluelinea Société Anonyme | 2.11 Million EUR | -51.967% |
Carmat SA | 57.64 Million EUR | 94.436% |
Diagnostic Medical Systems S.A. | 13.19 Million EUR | 75.697% |
Euromedis Groupe | 5.08 Million EUR | 36.936% |
Eurobio Scientific Société anonyme | 81.23 Million EUR | 96.051% |
Implanet S.A. | 1.38 Million EUR | -132.091% |
Median Technologies SA | 21.64 Million EUR | 85.178% |
SpineGuard SA | 1.87 Million EUR | -71.007% |
Theraclion SA | 1.95 Million EUR | -64.425% |
Euroapi S.A. | 15.5 Million EUR | 79.306% |
Guerbet SA | 360.51 Million EUR | 99.11% |